Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases R Cai, Y Zhang, JE Simmering, JL Schultz, Y Li, I Fernandez-Carasa, ... The Journal of clinical investigation 129 (10), 4539-4549, 2019 | 225 | 2019 |
Coronavirus disease 2019 case fatality and Parkinson's disease Q Zhang, JL Schultz, GM Aldridge, JE Simmering, NS Narayanan Movement Disorders 35 (11), 1914, 2020 | 70 | 2020 |
Abnormal development of cerebellar-striatal circuitry in Huntington disease AV Tereshchenko, JL Schultz, JE Bruss, VA Magnotta, EA Epping, ... Neurology 94 (18), e1908-e1915, 2020 | 59 | 2020 |
Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database JL Schultz, JA Kamholz, DJ Moser, SME Feely, JS Paulsen, PC Nopoulos Neurology 88 (9), 909-915, 2017 | 50 | 2017 |
The neurodevelopmental hypothesis of Huntington’s disease E van der Plas, JL Schultz, PC Nopoulos Journal of Huntington's disease 9 (3), 217-229, 2020 | 48 | 2020 |
Disease-modifying treatment of amyotrophic lateral sclerosis. J Schultz The American journal of managed care 24 (15 Suppl), S327-S335, 2018 | 41 | 2018 |
Evaluating depression and suicidality in tetrabenazine users with Huntington disease JL Schultz, A Killoran, PC Nopoulos, CC Chabal, DJ Moser, JA Kamholz Neurology 91 (3), e202-e207, 2018 | 39 | 2018 |
Melatonin may slow disease progression in amyotrophic lateral sclerosis: findings from the pooled resource open‐access ALS clinic trials database EM Bald, CS Nance, JL Schultz Muscle & nerve 63 (4), 572-576, 2021 | 36 | 2021 |
Comparing clinical outcomes of a pharmacist-managed diabetes clinic to usual physician-based care JL Schultz, KE Horner, DL McDanel, ML Miller, RL Beranek, RB Jacobsen, ... Journal of pharmacy practice 31 (3), 268-271, 2018 | 31 | 2018 |
A pilot to assess target engagement of terazosin in Parkinson's disease JL Schultz, AN Brinker, J Xu, SE Ernst, F Tayyari, AJ Rauckhorst, L Liu, ... Parkinsonism & related disorders 94, 79-83, 2022 | 27 | 2022 |
COVID-19 case fatality and Alzheimer’s disease Q Zhang, JL Schultz, GM Aldridge, JE Simmering, Y Kim, AC Ogilvie, ... Journal of Alzheimer's Disease 84 (4), 1447-1452, 2021 | 24 | 2021 |
Early pediatric chronic kidney disease is associated with brain volumetric gray matter abnormalities MA Solomon, E van der Plas, KE Langbehn, M Novak, JL Schultz, ... Pediatric research 89 (3), 526-532, 2021 | 22 | 2021 |
Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease E van der Plas, O Lullmann, L Hopkins, JL Schultz, PC Nopoulos, ... Pediatric research 91 (7), 1735-1740, 2022 | 21 | 2022 |
Gender expression, peer victimization, and disordered weight-control behaviors among US high school students AR Gordon, SB Austin, J Schultz, CE Guss, JP Calzo, ML Wang Journal of Adolescent Health 68 (6), 1148-1154, 2021 | 20 | 2021 |
Statin use and delayed onset of Huntington's disease JL Schultz, PC Nopoulos, A Killoran, JA Kamholz Movement Disorders 34 (2), 281-285, 2019 | 19 | 2019 |
Use of glycolysis‐enhancing drugs and risk of Parkinson's disease JE Simmering, MJ Welsh, J Schultz, NS Narayanan Movement Disorders 37 (11), 2210-2216, 2022 | 16 | 2022 |
Association of CAG repeat length in the Huntington gene with cognitive performance in young adults JL Schultz, C Saft, PC Nopoulos Neurology 96 (19), e2407-e2413, 2021 | 16 | 2021 |
Impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center BA Wright, SB Singh, JL Schultz, LJ Ramsey, KA Spading, LA Mascardo, ... Pediatric pulmonology 54 (10), 1591-1595, 2019 | 16 | 2019 |
Autonomic dysregulation as an early pathologic feature of Huntington disease JL Schultz, LA Harshman, JA Kamholz, PC Nopoulos Autonomic Neuroscience 231, 102775, 2021 | 15 | 2021 |
Human immunodeficiency virus infection in huntington’s disease is associated with an earlier age of symptom onset JL Schultz, PC Nopoulos, P Gonzalez-Alegre Journal of Huntington's disease 7 (2), 163-166, 2018 | 15 | 2018 |